Dapiprazole
Product Images NDC 53020-265

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapiprazole (NDC 53020-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baradaina, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1 Structure)

FDA Label Image

Principal Display Panel Container Label (Spl Image Container Label)

Principal Display Panel Container Label (Spl Image Container Label)
This is information about an ophthalmic solution medication containing dapiprazole hydrochloride and mannitol. It should be stored between 20°C to 25°C and once the diluent is added, it should be dissolved before dispensing. There are inactive ingredients listed in the carton. The medication should be dispensed within 21 days of opening, and the vial should be discarded after that. The medication is manufactured for Baradaina, LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.